Tuesday, March 3, 2009

CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today

CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today

Virtual Medical Event Available from the Convenience of a Computer www.CardioCareLive.com takes place entirely online Tuesday March 3 and Wednesday March 4 from 9:30 AM to 8:00 PM Eastern. Patch Adams, MD, the real physician behind the movie starring Robin Williams, is even slated to speak. To register now for free, visit cardioCareLive.com.

Needham, MA (PRWEB) March 3, 2009 -- CardioCareLive (http://www.CardioCareLive.com), the first-ever online-only conference for medical professionals who manage patients with cardiometabolic risk factors, begins today at 9:30 AM Eastern. Cardiologists, endocrinologists, primary care physicians and registered nurses can have their questions addressed live by leading experts in cardiometabolic care from the ease of a PC. This event offers live keynote presentations (http://cardiocarelive.com/en_CA/guest/app-agenda) with Q & A, peer networking and an exhibit floor, entirely online at CardioCareLive.com on Tuesday March 3 and Wednesday March 4 from 9:30 AM to 8:00 PM Eastern.

CardioCareLive features leading cardiovascular experts live via video, such as Louis Aronne, MD; Christie Ballantyne, MD; Roger Blumenthal, MD; Robert Eckel, MD; Peter Libby, MD; Laurie Mosca, MD; Richard Nesto, MD; Clyde Yancy, MD and more. Patch Adams, MD, the real physician behind the movie starring Robin Williams, is even slated to speak.

Acknowledging the busy lives of physicians, CardioCareLive offers continuing education (http://cardiocarelive.com/en_CA/guest/cme) at no cost and completely online, and all presentations will be available on-demand for ninety days after the event concludes. To view a complete list of speakers, agenda, or to register now for free, visit CardioCareLive.com.

About CardioCareLive

CardioCareLive.com, a medical conference which features "Improving Cardiometabolic Patient Outcomes" presented by Johns Hopkins Office of Continuing Medical Education, take place entirely online, enables healthcare practitioners and others interested in understanding and managing cardiometabolic risk factors to learn, connect and interact through powerful Web-based software and services.

CardioCareLive is produced, in cooperation with Johns Hopkins, by PlatformQ whose mission is to connect people, companies, organizations and associations worldwide to meet, interact and learn from leading experts and thought leaders through proven interactive tools at online events.

CardioCareLive and PlatformQ are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.

###



Contact Information Martha Collins

PlatformQ, LLC.

http://www.CardioCareLive.com

(617) 938-6008

Sal Giliberto

PlatformQ, LLC.

http://www.CardioCareLive.com

(617) 938-6006



Hospital Rating Site Launched, RateYourHospitalStay.com

Hospital Rating Site Launched, RateYourHospitalStay.com

RateYourHospitalStay.com is a free site where consumers can both rate a hospital (http://www.rateyourhospitalstay.com/rate_hospital) or look up hospitals to see how others have rated them.

Pasadena, CA (PRWEB) March 3, 2009 -- RateYourHospitalStay.com, http://www.rateyourhospitalstay.com, is a newly launched website that provides opinions and ratings of hospitals (http://www.rateyourhospitalstay.com/search) across the U.S. The site also allows people who have recently undergone a hospital stay to rate their experiences and share their opinions. The site is based on the premise that by providing an online mechanism to unite the opinions of those recently hospitalized with those who may be considering hospitalization, the information can help people make informed decisions about which health care facilities best fits their needs.

"Our mission with RateYourHospitalStay.com is to shine a light on unbiased assessments of patient care for other consumers who are often ill-informed of their choices," says Founder of RateYourHospitalStay.com Joseph Reed. "Through better, more complete and dynamic information, consumers will be able to separate the good hospitals from the bad."

Reed says most of the information about hospitals and healthcare facilities on the web today is provided by companies who are owned or controlled by those in the healthcare industry or groups who benefit from keeping information limited. RateYourHospitalStay.com is completely independent, dedicated to providing the best possible unbiased information to consumers. The site is not funded or supported by any hospital or healthcare corporation. Its support comes solely from the advertising sponsors on the site.

RateYourHospitalStay.com is also committed to being a free service. All that is required is registering in order to complete surveys and post comments. Registration is easy and simply requires having a valid email address. RateYourHospitalStay.com does not sell or give any private information to outside sources and is a member of the Ratings and Reviews Professional Association.

RateYourHospitalStay.com (http://www.rateyourhospitalstay.com/) surveys include questions on:

* Admissions Process

* Hospital Facilities

* Food and Nutrition

* Nursing Care

* Visitor Experience

* Discharge Process

The rating system is a five-star system with:

* 1 Star = Unacceptable

* 2 Stars = Poor

* 3 Stars = Average

* 4 Stars = Good

* 5 Stars = Excellent

All ratings for each hospital facility are combined and averaged to arrive at a score.

Currently there are over 4,500 U.S. hospitals listed on the RateYourHospitalStay.com website. If consumers don't find a particular hospital listed, it can easily be added to the database by contacting RateYourHospitalStay.com via the "Contact Us" page with the name, city and state of the hospital they wish to include. Within 72 hours it will be added to the site. People can also search by zip code to view information on all the hospitals in a particular area.

RateYourHospitalStay.com encourages people to include personal comments, both positive and negative, as long as they relate to a hospital experience. The survey is specific to hospital facilities and the treatment received in and by the hospital staff. The information not only helps individuals in choosing a hospital or facility that best fits their needs, but additionally, by making the information public, hospitals may see the need to reevaluate their patient care services. For more information, visit http://www.rateyourhospitalstay.com.

Contact:

Joseph Reed

626-356-3231

Joseph(at)JWReedOnLine.com

###



Contact Information Joseph Reed

RateYourHospitalStay.com

http://www.rateyourhospitalstay.com

626-356-3231



Monday, March 2, 2009

EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors In Support of National AMD Month - March 2009

EyeCare America Offers No-Cost Medical Eye Care to Qualified Seniors In Support of National AMD Month - March 2009

Age-related Macular Degeneration (AMD) is the leading cause of vision loss in people 65 years or older in the United States. According to the National Eye Institute, AMD affects more than 10 million Americans.

San Francisco, CA -- Age-related Macular Degeneration (AMD) is the leading cause of vision loss in people 65 years or older in the United States. According to the National Eye Institute, AMD affects more than 10 million Americans. Macular degeneration refers to the breakdown of the macula of the eye, where our sharpest central vision occurs. A person with macular degeneration may be able to see a clock on a wall, but not see the numbers, or walk into a room without bumping into furniture. Words may look blurred and straight lines may appear crooked.

As our population ages, and the "baby boomers" advance into their 60's and 70's, we will see a virtual epidemic of AMD. In fact, according to the National Eye Institute, it is estimated that Americans with moderate to severe AMD will reach 17 million by the year 2020.

In support of National AMD Month this March 2009, EyeCare America (www.eyecareamerica.org) encourages all seniors to see if they qualify for an eye exam at no out-of-pocket cost available through its AMD EyeCare Program by calling 1-866-324-EYES (3937). Recent studies also show that eating foods rich in antioxidants such as lutein, zeaxanthin, omega-3 fatty acids, beta carotene, vitamin C, vitamin E and zinc, may reduce the risk of AMD, or slow its progression in some people. In light of this, EyeCare America has developed a cookbook called Feast Your Eyes on This! which includes eye healthy recipes from celebrity chefs from across the United States. The complete cookbook is available for free online at www.eyecareamerica.org.

"Blindness and vision impairment have enormous personal, social and economic costs, limiting the activities of otherwise healthy and active people," said William Tasman, MD, Chair of EyeCare America's AMD EyeCare Program. "EyeCare America bridges the gap between the senior community and the quality eye care they need. By increasing awareness of eye diseases such as AMD and its risk factors, and connecting more people with exams and care, EyeCare America works to reduce preventable blindness in the U.S. thereby enabling older Americans to see clearly into the future, and and maintain maximum independence."

EyeCare America's AMD EyeCare Program is a year-round program that promotes annual eye exams for people 65 and older, raises awareness of AMD, provides the latest information about treatment options and low vision services, offers free AMD educational materials, and facilitates access to care at no out-of-pocket cost for those who qualify. The eye exams are provided by more than 7,000 dedicated volunteer ophthalmologists across the U.S. People may call the toll-free helpline at 1-866-324-EYES (3937), anytime, for themselves, family members and/or friends to see if they qualify to be referred to one of our volunteer ophthalmologists, or to request free AMD educational material.

Callers who have not seen an ophthalmologist in three or more years may be eligible to receive a comprehensive medical eye exam and, in most cases, up to one year of care at no out-of-pocket cost for any disease diagnosed during the initial exam.

The AMD EyeCare Program is designed for people at increased risk for AMD, but who have NOT been diagnosed and who:

•    Are age 65 and older

•    Are US citizens or legal residents

•    Have not seen an ophthalmologist in three or more years

•    Do not belong to an HMO or the VA

Eyeglasses, medicines, hospital services and fees of other medical professionals are not included.

About EyeCare America

Established in 1985, EyeCare America, the public service program of the Foundation of the American Academy of Ophthalmology, is committed to the preservation of sight, accomplishing its mission through public service and education. EyeCare America provides eye care services to the medically underserved and for those at increased risk for eye disease through its corps of 7,000 volunteer ophthalmologists dedicated to serving their communities. More than 90 percent of the care made available is provided at no out-of-pocket cost to the patients. EyeCare America includes programs for seniors, glaucoma, diabetes, AMD and children, and is the largest program of its kind in American medicine. Since its inception, EyeCare America has helped more than 1 million people. EyeCare America is a non-profit program whose success is made possible through charitable contributions from individuals, foundations and corporations. More information can be found at: www.eyecareamerica.org

Media Contact: Allison Neves, Director of EyeCare America Communications - 415.561.8518

Note to Editors and Producers: High-resolution images and interviews with EyeCare America spokespeople, physicians and patients available upon request.

###



Contact Information Allison Neves

American Academy of Ophthamology

http://www.eyecareamerica.org

415-447-0284



German Medical Advancement Reflects Major Improvement in Individuals with Common and Chronic Illnesses Related to Immune System Dysfunction

German Medical Advancement Reflects Major Improvement in Individuals with Common and Chronic Illnesses Related to Immune System Dysfunction

A new preparation highly beneficial in patients with ailments from common skin disorders to hepatitis or HIV, is now available in the US without a prescription. Oral intake of the GKL03 synthetic peptides induces modulation and regulation of the immune system. GKL03 (Thymrevit) is a demonstrably potent immmunomodulator effective in the short term.

Mannheim, Germany -- A new preparation highly beneficial in patients with ailments from common skin disorders to hepatitis or HIV, is now available in the US without a prescription. Oral intake of the GKL03 synthetic peptides induces modulation and regulation of the immune system. GKL03 (Thymrevit) is a demonstrably potent immmunomodulator effective in the short term.

This preparation was first used in 2004 on tumor patients whose immune system was significantly weakened by chemotherapy or radiotherapy which had been carried out or recently administered. All subjects felt significantly better in several chemotherapy phases each time GKL-03 was taken, and also had better excersise tolerance in endurance test. Since 2004, ongoing clinical trials conducted in Germany, has shown GKL-03 to be adventageous in those with tumourigenic disease, cancer or immuno deficiencies. There are unambiguous findings indicating GKL-03 can protect the body from opportunistic infections where the body has been damaged from pre-existing conditions such as chemotherapy, x-rays, or bacterial, fungal or latent viral infections. "Since such a short term improvement of immune disorders is extremely difficult to achieve, I venture to assume with all reserve a positive effect of the GKL-03" --- Dr. Med Knut Briken, Oncology/Immunobiological Cancer Aftercare, Berlin Germany.

Klett-Loch GmbH, a medium size company, located in Mannheim Germany is a top leader in research and development against immune system disorders for over 25 years. Biotechne Complex, Inc. (www.biotechne.com) located in Georgia is designated the North American representative since 1995 assisting in continued support and informational programs.

###



Contact Information Martin Wainright

Biotechne Complex, Inc.

http://www.biotechne.com

800-214-8631



Saturday, February 28, 2009

CheckOrphan Launches iWish to Commemorate Rare Disease Day

CheckOrphan Launches iWish to Commemorate Rare Disease Day

CheckOrphan, the leading news site for rare, orphan and neglected diseases, launches iWish, which allows people to visually (creative, artistic and realistic images) show their conception of these diseases through and image. In addition, people are invited to explain their imagery and add their iWish - which should convey creative solutions for a rare disease or for the community in general.

Basel, Switzerland (PRWEB) February 28, 2009 -- Today, CheckOrphan is launching one of its flagship features - iWish (http://www.checkorphan.org/content/iWish) - in conjunction with Rare Disease Day, February 28, which is an international effort to raise awareness for rare diseases and the needs of people affected by them.

To help commemorate this day, iWish is a way for people affected by, or working with, rare diseases to step forward and tell their stories through words and images. Currently, CheckOrphan is accepting iWish submissions in English, Spanish, French, German, and Italian.

Participants are asked to provide a text of up to 1,000 words describing a change or development they would like to see in the world of rare diseases - their iWish. They are also encouraged to discuss their experience with a rare disease or diseases, if applicable, and to provide and describe an image (a photograph or other creative image) that in some way complements or illustrates their text. Examples of some iWish contributions can be viewed at:

http://www.checkorphan.org/content/iWish

"People affected by a rare disease have the chance to show the world in an artistic or realistic way through a picture and words what it is like to have a rare disease," explains Ian Sowers, Head of Marketing and PR for CheckOrphan. "But, we also encourage industry professionals, physicians, researchers and others to explain want they encounter as well. This way the world will have a complete view of the problem, accompanied with ways to overcome the hurdles that rare, orphan and neglected diseases face."

CheckOrphan's goal is to allow people around the world to provide creative solutions, through their iWish. At the same time CheckOrphan offers people the opportunity to make an iWish come true. People who want to support an iWish can contact CheckOrphan and then CheckOrphan will contact the individual who submitted the iWish on behalf of the interested supporter.

"Rare, orphan and neglected disease need solutions. They are a huge drain on families and society in general," says Robert Derham, President of CheckOrphan. "So as the saying goes 'two heads are better than one' - we believe that 7 billion heads will be even better. Collectively we will be able to think outside of the box and start to bring solutions to the hundreds of millions of people that are affected with rare, orphan and neglected diseases."

Since its inception two years ago, CheckOrphan.org has become the leading online source of news about rare, orphan, and neglected diseases.

Recently re-launched with a new look and increased functionality, CheckOrphan is dedicated to being a complete web platform for rare diseases that unites and empowers researchers, physicians, professionals and, most importantly, those affected by rare diseases so that they can initiate change.

CheckOrphan's features include: a database of over 8,000 news articles (http://www.checkorphan.org/news) about rare diseases, events, clinical trials, treatments (http://www.checkorphan.org/node/8379), research publications, physician-researcher-hospital-organization-industry databases, videos, daily newsletters and more. Users can submit content for each feature

About CheckOrphan

CheckOrphan is the leading source of news about rare, orphan and neglected diseases. Its news database holds the largest concentration of articles about rare diseases, with over 8,000 entries. CheckOrphan's users benefit from several large databases that also include: events, treatments, research publications, physician-researcher-hospital-organization-industry databases, videos, daily newsletters and more. It is also home to iWish - every wish means hope for a better tomorrow.

CheckOrphan is a non-profit organization that encourages its visitors to submit content and information to the platform. CheckOrphan is always interested in meeting new partners and supporters. CheckOrphan would like to thank the Gebert Rüf Stiftung for its support. For more information about this foundation, please visit http://www.grstiftung.ch.

Contact:

CheckOrphan

Ian Sowers

Head of Marketing and PR

Tel: +41 61 267 0447

Mob: +41 79 719 5539

Robert Derham

President

Tel: +41 61 267 0447

Mob: +41 78 662 5231

###



Contact Information Robert Derham

CheckOrphan

http://www.checkorphan.org

+41 61 267 0447

Ian Sowers

CheckOrphan

http://www.checkorphan.org



Friday, February 27, 2009

Home Delivery Medical Offers New Glucose Meter With State-Of-The-Art Technology

Home Delivery Medical Offers New Glucose Meter With State-Of-The-Art Technology

Arkray Glucocard X-Meter, Dubbed The iPod Of Glucose Monitoring Systems, Is Just What Diabetics Have Been Waiting For. The Sleek, Bold And Simple New Look Of the Meter Is Taking The Diabetic Market By Storm.

Greenville, SC (PRWEB) February 27, 2009 -- For years, the diabetic community has been calling for a glucose monitoring system that is both functional and attractive. In recent years, many companies have developed smaller glucose monitoring systems, but until now, those systems required large blood samples and looked like toy phones. The new Glucocard X-METER (http://homedeliverymedical.com/weekly_specials11.aspx) from Arkray is what America's 23 million diabetics have been waiting for.

The X-Meter is designed with functionality, simplicity, and style. With its tiny blood sample size of only 0.3 microliters, the ability for alternate site testing, and a result time of only 5 seconds, the X-Meter saves your time and your fingers. The Glucocard X-SENSOR (https://store.homedeliverymedical.com/iwwida.pvx?;item?item_no=750050%20%20%20%20%20%20%20%20%201&source=sc?comp=gmi) is an auto-coded test strip that immediately turns on the meter eliminating the need for coding and buttons. This functionality is housed in a sleek white body that is nearly 10mm thick. With its bold look, large screen, and sleek profile, the X-Meter can easily be mistaken for an iPod.

Home Delivery Medical is an official Arkray Distributor and reports that the X-Meter is selling very well. Michael Laico, VP of Operations for Home Delivery Medical states, "It is easy to see why people like this product. It is innovative, functional, and most people think it is an MP3 player." Home Delivery Medical is considered to have the lowest prices on the X-METER Kit (http://homedeliverymedical.com/weekly_specials11.aspx) which includes the Meter, 60 Test Strips, Logbook, Control Solution, Lancing Device, 10 Lancets, and a carrying case. The X-Meter is free to those who are Medicare eligible and a professional staff is on-hand to process Medicare billing. The X-Meter can be shipped anywhere in America.

The medical industry is finally responding to the demands of the end user. While diabetics must continue monitoring their glucose levels, for once, they can do it in style. To find out more about the Glucocard X-Meter, visit Home Delivery Medical (http://www.HomeDeliveryMedical.com), or call 1-866-584-4038.

About Home Delivery Medical

Home Delivery Medical provides medical supplies, equipment, and home care health products focused on improving life at home. Shopping on Home Delivery Medical is reliable, economical, secure, and discreet. All orders for stock items placed before 4:00 pm EST are shipped the same day to anywhere in the nation. Medicare (http://homedeliverymedical.com/weekly_specials11.aspx) billing is handled by a well-trained and experienced staff, providing the maximum benefits and savings. With thousands of products and top brands available online and unparalleled customer service, Home Delivery Medical is the industry's premier source for online medical supplies and equipment. For more information, visit www.HomeDeliveryMedical.com or call toll free at 1-866-584-4038.

###



Contact Information Oliver Lollis

Home Delivery Medical

http://www.HomeDeliveryMedical.com

1-866-584-4038



Wednesday, February 25, 2009

Health/Nutrition News: New Berry On The Block Packs Twice The Antioxidants

Health/Nutrition News: New Berry On The Block Packs Twice The Antioxidants

The little-known black elderberry is "berry" good for your health; clinically-proven to support immune function.

Nottingham, UK (PRWEB) February 25, 2009 -- It's been widely known and touted that certain berries are high in antioxidants, thought to help boost the immune system and help fight off infectious diseases and viruses. The latest to make news is black elderberry (http://blackelderberry.info), the main ingredient in the dietary supplement Sambucol Black Elderberry (http://www.sambucolusa.com), which has twice the natural antioxidant capacity of blueberries and almost twice that of cranberries, according to the Dept. of Agriculture's ORAC rating (oxygen radical absorbance capacity).

Even better, you won't have to go berry picking to get this boost to your immune system now that Sambucol black elderberry dietary supplement (http://www.sambucolusa.com) is widely available in the U.S. Sambucol is the original black elderberry that was tested in published clinical trials and is made from a unique black elderberry extract - originally formulated by a virologist -- with a higher antioxidant capacity than most other fruits. Sambucol dietary supplements are produced from whole black elderberries and have the equivalent of up to 1,000 black elderberries in every 120 ml/4-ounce bottle and are manufactured using the same part of the plant, which has an impact on the consistency in quality and efficacy.

Here are some additional little-known facts about black elderberry:

•Throughout history, black elderberry has been used to treat colds, flu, fever, burns, cuts and more than 70 other maladies, from toothache to the plague. The medicinal benefits of the berry can be traced back to prehistoric times. Evidence of this use has been seen in Stone Age villages located at sites in Italy and Switzerland. Recipes were also discovered that showed black elderberry use in Ancient Egypt.

•The black elderberry, otherwise known as Sambucus nigra L, is a small shrub or bush that is native to most of Europe, northwest Africa and southwest Asia. It typically grows in areas that receive a lot of sunlight and can grow both in wet and dry fertile areas.

•In modern times, black elderberry has been used as a dietary supplement to help boost the immune system. Sambucol Black Elderberry is the original elderberry product sold in stores in more than 15 countries that has been researched and tested in published clinical trials showing it to help support the immune system. Sambucol's unique formulation and extraction process preserves and maximizes the naturally occurring health benefits of the berry.

•The Sambucol line of products (http://www.sambucolusa.com/sambucol-range.htm) is now widely available nationwide at major retailers, including health food stores, vitamin retailers including Vitamin Shoppe, pharmacy chains, including Rite Aid, Walgreens and CVS, independent drug stores, and online at drugstore.com. Go to www.sambucol.com for complete store availability and more information about the health benefits of black elderberry.

Note to Media:

For more information or to set up an interview with Claire Wheeler, M.D., an integrative health expert who has recommended Sambucol black elderberry to her patients for many years, contact Rachahd Tosado at Robin Leedy & Associates, (914) 241-0086 ext. 15, or rtosado (at) robinleedyassociates (dot) com. Visit the Sambucol online newsroom at http://www.corporatenews.net/cgi-bin/pc200v3.php?pccl=24859.

###



Contact Information Rachahd Tosado

Sambucol

http://www.sambucolusa.com

914-241-0086



Texas Oncology Encourages Texans To Kick Colorectal Cancer with Screenings

Texas Oncology Encourages Texans To Kick Colorectal Cancer with Screenings

Texas Oncology is inviting Texans to kick colorectal cancer by encouraging friends and loved ones to go for a routine colorectal cancer screening. Colorectal cancer is the second-leading cancer killer of men and women combined in the United States, and the disease is estimated to have claimed 9,570 Texans in 2008.

Paris, Texas (PRWEB) February 24, 2000- - Texas Oncology is inviting Texans to kick colorectal cancer (http://www.texasoncology.com/media-center/fact-sheets/colorectal-cancer/kick-colorectal-cancer.aspx) by encouraging friends and loved ones to go for a routine colorectal cancer screening. Colorectal cancer (http://www.texasoncology.com/media-center/fact-sheets/colorectal-cancer.aspx) is the second-leading cancer killer of men and women combined in the United States, and the disease is estimated to have claimed 9,570 Texans in 2008.

Colon and rectal cancers occur with equal frequency in both sexes. It is vital that both men and women age 50 and over and those with increased risk factors be screened regularly (http://www.texasoncology.com/media-center/fact-sheets/colorectal-cancer.aspx) for this deadly disease. Despite the high likelihood of detection with screening, it is projected that 40 percent of the over-50 population in the United States, more than 39 million people by 2010, will not be screened for colorectal cancer. If all people over age 50 were screened routinely, research shows at least half of colorectal cancer deaths could be prevented.

Colorectal cancer often lacks symptoms in its early stages, and because almost all colorectal cancer cases are diagnosed in patients ages 50 and up, regular screening helps lead to early detection, which increases the five-year survival rate from the disease to 90 percent.

"Regular colorectal cancer screenings save lives. Your doctor can recommend the best screening for you, but a colonoscopy is the most common," said Dr. Michael Kerley (http://www.texasoncology.com/providerresults.aspx?id=1410&terms=%40Locations_Location_8+274), medical and radiation oncologist at Texas Oncology-Paris. "Everyone over age 50 should make routine colorectal cancer screenings a priority to kick colorectal cancer before it strikes or catch it early when it's most treatable."

Risk Factors

Besides age and race, other risk factors for colorectal cancer include:

•Family History: People with a family history of colorectal cancer have a greater risk of being diagnosed with the disease.

•Diet: A lower chance of being diagnosed with colorectal cancer is a good reason to stay in shape. Overweight and obese people have a higher risk of developing the disease.

•Lynch Syndrome: This inherited condition affecting the body's genes increases the likelihood of a colorectal cancer diagnosis. In many cases, the positive diagnosis occurs before age 45. Texas Oncology has genetic testing available at some locations to determine if patients have the gene mutation associated with Lynch Syndrome.

•Other Health Problems: Diabetics and people who have a history of polyps and inflammatory bowel disease also have an increased risk for a positive diagnosis.

Screening Types

Screening tests for rectal and colon cancer are not as difficult as many people perceive them to be. In fact, most patients tolerate the screenings very well. Physicians can recommend several different screening tests for colorectal cancer. Among them, a Fecal Occult Blood Test (FOBT) or Fecal Immunochemical Test checks for blood in the stool. Another option is a sigmoidoscopy. During this procedure, a physician uses a tube with a light connected to a tiny video camera to analyze the rectum and lower part of the colon.

The most common screening test is a colonoscopy, where the rectum and entire colon are examined through a scope to detect growths or polyps that could potentially pose a threat (see sidebar graphic for a description of a colonoscopy).

March is colorectal cancer awareness month. For more information on kicking colorectal cancer, visit TexasOncology.com (http://www.texasoncology.com).

About Texas Oncology

Texas Oncology delivers high-quality cancer care with leading-edge technology and advanced treatment and therapy options available to help patients achieve "More breakthroughs. More victories." in their fights against cancer, right in their own communities. Texas Oncology, a pioneer in community-based cancer care, is an independent oncology practice with sites of service throughout Texas and southeastern New Mexico.

Texas Oncology patients have the opportunity to take part in some of the most promising clinical trials in the nation for a broad range of cancers. In fact, Texas Oncology has played an integral role in gaining Food and Drug Administration (FDA) approval for 24 of the latest 30 cancer therapies.

Texas Onocology is affiliated with US Oncology, the nation's foremost cancer treatment and research network accelerating the availability and use of evidence-based medicine and shared best practices. With more than 1,250 physicians at 480 locations in 39 states, the US Oncology network provides Texas Oncology with access to the latest advancements in therapies, clinical research, and technology, as well as best-in-class clinical and operational processes that help to advance the quality, safety, and cost effectiveness of cancer care.

For more information, visit http://www.texasoncology.com or call 1-888-864-I CAN (4226).

###



Contact Information Alison Zvolanek

214-665-1319



Tuesday, February 24, 2009

New survey: Flu Shot Still not Catching on, Especially at Retail Clinics

New survey: Flu Shot Still not Catching on, Especially at Retail Clinics

A new survey from global market research firm Synovate shows that less than half of Americans (42%) received the flu vaccine during the past six months. Of those, only 10% received it at a pharmacy and just 4% received it at a retail clinic.

Chicago, IL (PRWEB) February 24, 2009 -- According to a new survey by leading market research firm Synovate, less than half of Americans (42%) received the flu vaccine during the past six months. Of those, only 10% received it at a pharmacy and just 4% received it at a retail clinic.

Although there is a much higher rate of flu vaccination among older Americans 65+ (80%), especially compared to those in younger age groups, this is still lower than the federal government's target of 90% flu immunization for the elderly.

"While most older Americans have accepted the importance of the flu shot, adoption among those who are younger is still quite low," said Terri Crudup, Vice President for Synovate's Healthcare practice. "This is likely because the messages they've heard have focused on the elderly and those working with people who are ill - such as hospital workers - needing it more than the general population."

Among respondents with at least one dependent in their household, less than half (42%) report that their dependent(s) received the flu vaccine in the past six months, and the majority of them (74%) obtained the flu vaccine from their pediatrician's office.

Of those who had obtained the flu vaccine in the past six months, the majority report having received the vaccine either from their doctor's office (43%) or from their employer (23%). Pharmacies and retail clinics in large stores were less popular venues, especially among those aged 18 to 44, suggesting either low patient awareness or low acceptance of such venues for healthcare access.

"Even though retail clinics are actively advertising their ability to give the flu vaccine, it's clear that people are not often using them for that purpose," said Crudup. "This may be because they don't trust retail clinics, they think that their health insurance will only cover the flu vaccine if it's obtained at a doctor's office and / or that they receive their flu shot when they're visiting the doctor for another reason."

Not surprisingly, people in the lowest annual household income bracket (under $25K) are significantly less likely to obtain the flu vaccine compared to those in higher income brackets.

The survey was conducted by Synovate Healthcare (www.synovate.com/healthcare) via Synovate's Omnibus service (www.synovate.com/whatwedo/omnibus-research) with a nationally representative sample of 879 heads of household ages 18+ during January 2009.

About Synovate

Synovate, the market research arm of Aegis Group plc, generates consumer insights that drive competitive marketing solutions. The network provides clients with cohesive global support and a comprehensive suite of research solutions. Synovate employs over 6,000 staff across 62 countries.

For more information on Synovate visit www.synovate.com.

###



Contact Information Jennifer Chhatlani

Synovate

http://www.synovate.com

1-312-526-4359



Dance Exercise Still The Best Way To Lose Weight Fast & Get In Shape In Tight Economy.

Dance Exercise Still The Best Way To Lose Weight Fast & Get In Shape In Tight Economy.

Many people are abandoning gym memberships and are opting to buy exercise videos to help them lose weight on a budget. Fitness expert Kenn Kihiu says despite latest fitness gimmicks, dance exercise has stood the test of time and is still the best and least expensive way to burn body fat and quickly get in shape while having fun.

Washington, DC (PRWEB) February 24, 2009 -- Exercise videos (http://www.dancexfitness.com) are now the hottest trend as family budgets continue to shrink. Sales are up 65 percent year-on-year according to Tesco. As consumers face cutbacks in the tough economy many are ditching their gym memberships and are now choosing to exercise in the comfort of their homes. Many have realized that exercise videos are cheap, convenient and can be used regardless of the weather.

One of the best selling dance exercise videos (http://www.dancexfitness.com) dominating the market is 'DanceX - Total Body Cardio.' This new exercise video features some of the best dance music from around the globe. It's also fun and very easy to follow even for those with two left feet.

The DanceX (http://www.dancexfitness.com) workout is a much welcomed and needed breath of fresh air in the current hip hop age of complicated exercise videos. The primary reason for the surge in popularity is because DanceX will meet you where are in terms of your talent and fitness ability.

Instead of making dance exercise difficult, it features fun easy to follow dance moves that are mostly low impact. DanceX is part dance, part aerobics and completely fun and not to mention a total body workout. Perfect for those who want to get fit, feel younger and have fun -- while traveling around the globe with some of the hottest music from around the world.

DanceX features the creator Kenn Kihiu a well known consumer health and fitness expert who has a dazzling smile and is choke-full of encouragement, and contagious enthusiasm. When producing this video he opted to use real people and not just fitness models who are 5'7" and 110 lbs. For example one of the background exercisers looks like your average full figured woman in her forties who seems to be having a lot of fun but also fighting to keep up with Kenn.

When it comes to losing weight and getting in shape, Kihiu is a dance exercise (http://www.dancexfitness.com) evangelist because he doesn't know of any other type of workout that can be so effective and yet be so much fun. "Consistency yields results and people will only exercise regularly and more passionately if they are having fun" Kihiu says.

Kenn's new dance exercise videos combine incredible music from around the world (Disco, Latin dance, 50's, Bhangra, Africa, Brazilian Samba, Irish Dance, Classical Music, and Soul Dance) with fun dance exercise moves everyone will love such as The Chicken, Hitch Hike, Disco Rolls, John Travolta Point, Irish Kicks, The Twist, and many others.

During the DVD's 42-minute easy-to-follow dance exercise workout, Kenn well known for his energy and sense of humor calls out the moves in advance so there is no need to memorize them. "The only requirement needed is a heartbeat!" says the charming and motivating Kenn Kihiu.

'DanceX - Everybody's Workout: Total Body Cardio.' Is only available at http://www.dancexfitness.com and retails at $24.95 with free shipping for a limited time. It also features '7 Nutrition Tips for Improving Your Health,' an "8 Minute Abs Workout, a danceX Promo Trailer, a 'Move Your Body, Move Your Life' featurette.

###



Contact Information Kenn Kihiu

301-960-4968



Monday, February 23, 2009

Babies Learn Music While Sleeping

Babies Learn Music While Sleeping

Early screening and treatment for infants with hearing problems, and the ability to computer-generate musical scores, are two very different possible outcomes of some "off-the-wall" research.

Brussels, Belgium (PRWEB) February 23, 2009 -- Babies learn music while sleeping.

Early screening and treatment for infants with hearing problems, and the ability to computer-generate musical scores, are two very different possible outcomes of some "off-the-wall" research.

Until recently, little has been known about the perceptions humans have when they enter the world.

Although adult perception has been extensively researched, how, or even if, the brains of newborn babies perceive patterns in the world remained a mystery.

That mystery has been at least partially solved by an EU-funded research (http://cordis.europa.eu/ictresults/index.cfm?section=home&tpl=eu-funded) project, EmCAP (http://www.iua.upf.edu/mtg/emcap/), which brought together what many would consider an unlikely consortium, comprising both neuroscientists and music technologists.

What project coordinator Susan Denham describes as "blue-sky thinking" on the part of her and her colleagues when they initially proposed the project led to experiments involving playing music to newborn babies.

Scanning sleeping babies

In the experiments, sleeping babies were hooked up to an encephalograph (EEG), an instrument able to measure brain activity using electrodes placed on the scalp.

The babies were then played music - to be more exact, simplified tone sequences - to test what sort of patterns they were sensitive to and whether they would predict what was coming next based on what had gone before.

"The babies were presented with sequences of sounds of different tone colour - different musical instruments, if you like - but all of the same pitch. Occasionally, you play a sound of a different pitch and watch the EEG to see if they produce a distinctive reaction to this deviant sound," explains Denham. Similar tests were done to see if babies were sensitive to rhythmic and melodic patterns, too.

Denham says while this sort of technique has been used for many years on adults to measure pre-conscious detection of unexpected events, it has seldom been used with newborns. The big advantage is that it can work even when somebody is unconscious. So the babies being asleep was not a problem.

Rocking in the cradle

The results were exciting, demonstrating newborns had a sense of pitch from birth, and this was not something learned through experience as had previously been thought. The experiments showed they are even sensitive to the beat in music.

"The bottom line is we come into the world with brains that are continually looking for patterns, and telling us when there is something unexpected we should learn about," says Denham.

István Winkler, who conducted the baby research, concludes this capability allows babies to learn about their environment and the important actors within it.

The discoveries may be applied to developing early screening techniques and treatments for cognitive hearing problems. The screening currently in use simply measures how hard of hearing people are as opposed to the nuances of their actual perceptions.

"Research is needed to determine the norm - and how much variation there is from it - to prevent false diagnoses when a baby is simply developing slowly," Denham says. But then it should be possible to spot defects at a very early stage and treat them while the brain is still malleable.

New light on music cognition

The research has thrown new light on music cognition and brought practical benefits to the music technologists involved in the project.

"While it remains unclear whether a capacity for music is rooted in nature, rather than nurture, it is clear that musical competence is a special human capacity, shared across ages and cultures." says project partner, Henkjan Honing.

Although the ability to detect musical patterns is present from birth, music cognition develops throughout life. However, music cognition is influenced not so much by musical expertise, as by experience. According to Honing, "Frequent listening to a certain musical genre allows listeners without formal musical training to become experts in that musical style."

Computers mimic the brain

Details revealed by the experiments about the way the brain checks and adjusts its expectations made it possible to develop computer programmes that mimic these processes.

Researchers in EmCAP (http://www.iua.upf.edu/mtg/emcap/) developed a generic algorithm, basically a bit of smart software, able to detect violations of expected pitch and rhythmic structure, with tonality soon to be added to the list.

"We did the modelling at two levels, one trying to emulate brain function and perception in a simplified but still fairly detailed way, and the other tailored more for practical use in music processing systems," Denham says.

What this will mean in practise, is the future development of artificial cognitive music systems able to "listen" to music and produce a score in real time showing which instruments play which notes. Project partner Xavier Serra suggests that the next generation of music processors will be based on algorithms that imitate how humans process music.

Further projects are planned on the back of EmCAP (http://www.iua.upf.edu/mtg/emcap/), including one starting in March 2009, which will use sounds to detect behavioural patterns of living creatures.

Media note: This feature can be republished without charge provided ICT Results (http://cordis.europa.eu/ictresults) is acknowledged as the source at the top or the bottom of the story. You must request permission before you use any of the photographs on the site. If you do republish, we would be grateful if you could link back to the ICT Results (http://cordis.europa.eu/ictresults) site (http://cordis.europa.eu/ictresults). Let us know if you republish so as to help us provide you with a better service. If you want further contact information on any of the projects cited in this story please contact us.

###



Contact Information Christian Nielsen

ICT Results

http://cordis.europa.eu/ictresults

+32 2 639 02 77



Thursday, February 19, 2009

Pediatric Scenarios in Development for Use With Laerdal's SimBaby™ Infant Simulator

Pediatric Scenarios in Development for Use With Laerdal's SimBaby™ Infant Simulator

Scenarios built around the AHA's Pediatric Advanced Life Support (PALS) Course.

Wappingers Falls, NY (PRWEB) February 19, 2009 -- Laerdal Medical Corporation, one of the world's leading providers of Healthcare Solutions, has partnered with the American Heart Association to release new scenarios for the American Heart Association Pediatric Advanced Life Support (PALS) Course for use with Laerdal's SimBaby Infant Simulator.

The PALS scenarios are based on science evidence from the 2005 AHA Guidelines for CPR and ECC and a new teaching methodology. The goal of the PALS course is to aid the pediatric healthcare provider in developing the knowledge and skills necessary to efficiently and effectively manage critically ill infants and children, resulting in improved outcomes.

The scenarios address major learning objectives geared toward critical pediatric care. These scenarios can be used not only in conjunction with the association's PALS courses, but in a variety of settings where assessment and management of critical ill newborns is a priority. The package contains 21 core scenarios and four skills teaching scenarios. All core scenarios require learners to take critical action steps using a systematic approach in order to successfully complete the scenarios.

The 21 core scenarios are divided into three main areas: Respiratory scenarios, Shock scenarios and Cardiac scenarios. The four skills teaching scenarios allow the instructor to work with participants in a manner that allows for more coaching and hands-on time teaching of CPR, airway management and other relevant psychomotor skills.

The PALS scenarios are expected to be available in March 2009 for $3,750.

Laerdal Medical, one of the world's leading providers of Healthcare Solutions, is dedicated to helping save lives with products and services for Simulation, Airway Management, Immobilization, Basic Life Support, Advanced Life Support, Patient Care, Self-Directed Learning, and Medical Education. Additionally, a complete line of Education and Technical Services, Courseware and Consulting Services is available. Laerdal is pleased to serve all health care providers and educators, from the lay rescuer to the medical professional. For more information, visit www.laerdal.com.

###



Contact Information Jolynn Oblak

Laerdal Medical Corporation

http://www.laerdal.com/document.asp?subnodeid=39089259

845-297-7770



Landmark Trial Provides Vital Information for Cardiac Disease Treatment

Landmark Trial Provides Vital Information for Cardiac Disease Treatment

NorthShore University HealthSystem Ted Feldman, M.D., Lead Investigator

Evanston, IL. -- NorthShore University HealthSystem (http://www.northshore.org/) (NorthShore) has played a leading role in a landmark clinical trial comparing two forms of treatment for patients with severe coronary artery disease (CAD). The results were published on-line in this week's issue of the New England Journal of Medicine.

The SYNTAX trial was a clinical research study that compared percutaneous coronary intervention (PCI) with drug-eluting stents and coronary artery bypass surgery (CABG) in patients with three-vessel and left main coronary disease. The trial results did not show any statistically significant differences between PCI and CABG in rates of death or heart attack, an excess of stroke in the CABG treated patients, and a greater need for repeat PCI procedures in the stent treated patients. These are better outcomes for PCI than have been seen in prior trials in less complex patients.

"At NorthShore, we experienced stunning outcomes in patients whose only option would have previously been bypass surgery," said Ted Feldman, M.D, F.S.C.A.I., Director of Cardiac Catheterization Laboratory, NorthShore University HealthSystem, and a lead investigator of the trial. "The data in this study will provide cardiologists with additional information as they determine treatment therapy for patients with complex CAD."

The trial is the first randomized, controlled clinical trial to compare these two treatments in patients with left main disease and/or three-vessel disease, who are typically treated with CABG and represent a population with far more complex anatomy and advanced disease than those studied in prior drug-eluting stent (DES) clinical trials.

There were 1,800 patients enrolled in the randomized arm of the trial. All patients were assessed by a multidisciplinary team including an interventional cardiologist and a cardiac surgeon. If both the cardiologist and surgeon felt that they could offer equivalent complete revascularization, patients were randomized 1:1 into one of the two treatment strategies. If either the cardiologist or surgeon felt that one or the other revascularization technique was the preferred option, due to technical considerations or co-morbidity, for example, then patients were recruited into one of two parallel, nested registries for PCI or CABG. Thus, patients in the PCI registry had been rejected for cardiac surgery.

About NorthShore University HealthSystem

Headquartered in Evanston, Ill., NorthShore University HealthSystem (NorthShore) is a comprehensive, fully integrated, healthcare delivery system that serves the greater North Shore and northern Illinois communities. The system includes three Hospitals--Evanston Hospital, Glenbrook Hospital and Highland Park Hospital--and a fourth, Skokie-based Rush North Shore Hospital, to be added in January 2009. In addition, the healthsystem has more than 2,000 affiliated physicians, including a 550-physician, multispecialty physician group practice with over 70 office locations-- NorthShore University HealthSystem Medical Group. Further, NorthShore is committed to excellence in its academic mission and supports teaching and research as the principal teaching affiliate of the University of Chicago's Pritzker School of Medicine. The NorthShore University HealthSystem Research Institute, with more than $100 million of grants, focuses on clinical and translational research, including leadership in outcomes research and clinical trials.

NorthShore has annual revenues of $1.5 billion and a staff of more than 8,000. The healthsystem has significant capabilities in a wide spectrum of clinical programs, including cancer, heart, orthopaedics, high-risk maternity and pediatrics. NorthShore is a national leader in the implementation of innovative technologies, including electronic medical records, (EMR ). In 2003, the healthsystem was among the first in the country to successfully launch a systemwide EMR with demonstrable benefits in quality, safety, efficiency and service to patients. NorthShore has been recognized by multiple national organizations for this notable achievement. Visit http://www.northshore.org/

CONTACT: Amy Ferguson

Senior Director, Public Relations

NorthShore University HealthSystem

(847) 570-3146

###



Contact Information Amy Ferguson

Northshore University HealthSystem

http://www.northshore.org/

847-570-3146